Senior Management

CHU Swee Yeok
Chief Executive Officer & President

Ms Chu joined EDB Investments Pte Ltd (EDBI) as its Chief Executive Officer in late 2008, bringing with her over 20 years of track record and extensive experience in equity investments of start-up to growth and late-stage ventures, strategic planning, business and technology development..

Prior to EDBI, Ms Chu was the CEO of Bio*One Capital Pte Ltd since 2004. Under her leadership, Bio*One became a globally recognised and reputable investment fund manager with a portfolio of over 50 therapeutics, medical technology and services companies worldwide and in Singapore.

Previously Ms Chu held major stints at the Singapore Economic Development Board (SEDB) and the Agency for Science & Technology Research where she played a pioneering role in developing and implementing key industry and R&D strategies leading to the growth of the biomedical sector as a major pillar of Singapore's economy today. At SEDB she was instrumental in establishing several venture funds since 1990 and providing oversight to their management. Ms Chu was also responsible for many successful negotiations with global MNCs relating to their R&D, manufacturing and headquarters activities in Singapore.

Besides the board of EDBI, Ms Chu also serves on the boards of Merlion Pharmaceuticals Pte Ltd, Singapore-Suzhou Township Development Pte Ltd, and Alexandra Health Endowment Fund.

Laura CHANG
Deputy Director, Legal

Laura has over ten years of experience as lawyer and corporate trust banker. She was an in-house legal counsel in a German financial institution responsible for corporate banking portfolio of Singapore branch, and a corporate trust banker in an US financial institution where she was involved with a significant portfolio of corporate trust and agency services in the Asia Pacific region.

Serena CHO
Director, Corporate Planning and Organisation

Serena has over fifteen years of experience spanning human resource management, policy formulation and implementation, organisational change management, planning, and investments.  Serena was Vice President at Bio*One Capital, EDBI’s dedicated fund manager for biomedical sciences, where she served on several Boards of Directors.  She currently heads Corporate Planning and Organisation, the latter encompassing Human Resources and Administration. 

 Prior to joining EDBI, Serena was Director (Compensation) in a leading global research and academic institution with 6,000 employees.  Serena has previously been active in scientific research, and participated in Singapore’s diplomatic missions.  She graduated with First Class Honours from the National University of Singapore.

CHOO Heng Tong
Executive Vice President, Investments

Heng Tong holds dual appointments as Executive Vice President (Investments) at EDBI and Bio*One Capital, its dedicated biomedical sciences investment subsidiary. He is responsible for EDBI’s strategic growth capital for local companies as well as venture investments in biomedical sciences, and also oversee EDBI’s operations in the United States. He has over 15 years of experience in investments and industry development; including M&As, strategic planning, business development, and international growth into new markets, involving both multi-nationals and start-up organizations. He was previously with Singapore Economic Development Board where he worked with various industries such as biotechnology, pharmaceutical, and engineering companies to grow their business and operations in Asia. Currently, Heng Tong serves on the board of Maccine Pte Ltd, S*Bio Pte Ltd, QT Vascular Pte Ltd, Jurong Aromatics Corporation Pte Ltd and SPRING’s Growth Enterprise Fund Pte Ltd.

Eugene KHOO
Executive Vice President, Corporate Finance

Eugene has over twenty years of experience in investment, business development, strategic planning and market studies. Eugene was Vice President at OCBC Capital Management, the venture capital arm of Oversea-Chinese Banking Corporation. He has also held various positions at SISIR International Pte Ltd, the investment arm of a Singapore statutory board, where he provided business development and other support.

LEE Li Ting
Deputy Director, Finance

Li Ting has over fifteen years of experience in finance and accounting. Prior to joining EDBI, she held finance positions in public listed company and US MNCs where she managed a team of finance staff. Her experiences include internal audit of companies in China, merger and acquisition, and treasury functions.

Jeremy LOH
Vice President, Investments

Jeremy began his investment career with Bio*One Capital in 2008 with the medtech investment group. In 2009, he was posted to California to lead EDBI’s US investment activities there and also served on the boards of US portfolio companies such as Contour Energy, Sotera Wireless, Amaranth Medical and goBalto Inc.

Prior to EDBI, Jeremy was a researcher trained by A*STAR, Nanyang Technological University, University of Southampton and Imperial College London and held multiple patents for diagnostic and bio-artificial organ applications. In 1998, he spearheaded an engineering team developing autonomous machines in a robotic start-up that has been subsequently acquired.

POON Thong Yuen
Vice President, Investments

Thong Yuen spent 3 years in Boston leading EDBI’s biomedical sciences, and later internet & digital media and clean technology investment activities covering the East Coast of US. Prior to that he was with the biomedical investment team. He has more than 8 years of investments experience. Thong Yuen earned his doctorate in Medicinal Chemistry and honours degree in Pharmacy from the National University of Singapore and currently serves on the boards of Amaranth Medical, Forma Therapeutics.

TAM Hock Chuan
Senior Vice President, Investments

Hock Chuan has over twenty years of investment experience in private equity and venture capital. He started his career in broadcasting where he was involved in developing and investing in new businesses. He had earlier held investments roles in Temasek Holdings, Vertex Venture Management and Accuron Technologies, a precision engineering company. In 2007, Hock Chuan joined the technology commercialisation arm of A*STAR - Exploit Technologies - to help incubate and spin-off companies founded on A*STAR intellectual properties. Prior to joining EDBI, he was with World Bank’s International Finance Corporation (IFC), focusing on ICT investments in East Asia Pacific. Currently, he serves on the board of Triton Water AG.

Belinda YEOH
Deputy Director, HR

Belinda  brings with her extensive experience in  Human Resources (HR) with focus on HR Business Partnering, Staff Attraction and Retention, Talent Management, as well as  Compensation and Benefits, with both regional and global coverage. Prior to EDBI, Belinda was the Vice President of HR in a European global bank. Besides banking, she had other HR management experience in a government linked company and multi-national high tech manufacturing firm where she managed a team of HR staff. Belinda is a Business graduate from National University of Singapore.